What is she best known for?
The fields of study she is best known for:
- Gene
- Internal medicine
- DNA
Duchenne muscular dystrophy, Dystrophin, Muscular dystrophy, Exon skipping and Genetics are her primary areas of study.
Her Duchenne muscular dystrophy study combines topics in areas such as Nonsense mutation, Computational biology, Eteplirsen and Bioinformatics.
Her research integrates issues of Clinical trial, Premature death and Morpholino in her study of Dystrophin.
Her Muscular dystrophy study incorporates themes from Phenotype and Immunology, Pathogenesis.
Exon skipping is a primary field of her research addressed under Exon.
In general Genetics, her work in Point mutation, Gene, Intron and Biopanning is often linked to Selection linking many areas of study.
Her most cited work include:
- Local Dystrophin Restoration with Antisense Oligonucleotide PRO051 (728 citations)
- Systemic administration of PRO051 in Duchenne's muscular dystrophy. (598 citations)
- Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. (437 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Duchenne muscular dystrophy, Dystrophin, Exon skipping, Muscular dystrophy and Exon.
Her study in Duchenne muscular dystrophy is interdisciplinary in nature, drawing from both Clinical trial and Bioinformatics.
Her research in Dystrophin intersects with topics in Phenotype, Eteplirsen and Pharmacology.
In her study, which falls under the umbrella issue of Exon skipping, In vivo is strongly linked to Molecular biology.
Her Muscular dystrophy research is multidisciplinary, incorporating elements of Immunology and Drisapersen.
Her Exon research incorporates themes from Mutation, RNA splicing and Cell biology.
She most often published in these fields:
- Duchenne muscular dystrophy (70.80%)
- Dystrophin (45.20%)
- Exon skipping (37.60%)
What were the highlights of her more recent work (between 2017-2021)?
- Duchenne muscular dystrophy (70.80%)
- Dystrophin (45.20%)
- Muscular dystrophy (34.00%)
In recent papers she was focusing on the following fields of study:
Annemieke Aartsma-Rus mainly focuses on Duchenne muscular dystrophy, Dystrophin, Muscular dystrophy, Internal medicine and Exon.
She has researched Duchenne muscular dystrophy in several fields, including Exon skipping, Disease, Pathology and Bioinformatics.
Annemieke Aartsma-Rus interconnects Molecular biology, Computational biology and Morpholino in the investigation of issues within Exon skipping.
The Dystrophin study combines topics in areas such as Phenotype, Cohort and Cell biology.
Her biological study deals with issues like Eteplirsen, which deal with fields such as Drisapersen.
Her work deals with themes such as Endocrinology and Oncology, which intersect with Internal medicine.
Between 2017 and 2021, her most popular works were:
- Therapeutic developments for Duchenne muscular dystrophy. (89 citations)
- The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy. (30 citations)
- RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases (30 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- DNA
Her primary scientific interests are in Duchenne muscular dystrophy, Muscular dystrophy, Clinical trial, Disease and Dystrophin.
Her Duchenne muscular dystrophy research integrates issues from Exon skipping, MEDLINE and Bioinformatics.
Her Exon skipping research is within the category of Exon.
Her Muscular dystrophy research includes elements of Creatine, Metabolomics, Genome editing, Protein function and Computational biology.
The concepts of her Dystrophin study are interwoven with issues in Healthy individuals and Medical physics.
Her studies in Molecular biology integrate themes in fields like Cardiac muscle, RNA splicing and Polymerase chain reaction, Nested polymerase chain reaction.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
